![Oestrogen‐dependent satellite cell activation and proliferation following a running exercise occurs via the PI3K signalling pathway and not IGF‐1 - Mangan - 2014 - Acta Physiologica - Wiley Online Library Oestrogen‐dependent satellite cell activation and proliferation following a running exercise occurs via the PI3K signalling pathway and not IGF‐1 - Mangan - 2014 - Acta Physiologica - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/900ed7fa-5a65-42ac-9353-51c69d465637/apha12317-fig-0002-m.jpg)
Oestrogen‐dependent satellite cell activation and proliferation following a running exercise occurs via the PI3K signalling pathway and not IGF‐1 - Mangan - 2014 - Acta Physiologica - Wiley Online Library
![Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.14.116/asset/images/medium/figure3.gif)
Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics
![Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.14.116/asset/images/medium/figure2.gif)
Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics
![IJMS | Free Full-Text | Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted? | HTML IJMS | Free Full-Text | Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted? | HTML](https://www.mdpi.com/ijms/ijms-16-13760/article_deploy/html/images/ijms-16-13760-ag-550.jpg)
IJMS | Free Full-Text | Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted? | HTML
![Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.14.116/asset/images/medium/figure1.gif)
Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers | Pharmacogenomics
![On the composition of luminescence spectra from heavily doped p-type silicon under low and high excitation - ScienceDirect On the composition of luminescence spectra from heavily doped p-type silicon under low and high excitation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S002223131630583X-gr4.jpg)
On the composition of luminescence spectra from heavily doped p-type silicon under low and high excitation - ScienceDirect
![PDF) Waste Biorefineries: Future Energy, Green Products and Waste Treatment.pdf | Dr Mohammad Rehan and Dr. Abdul-Sattar Nizami - Academia.edu PDF) Waste Biorefineries: Future Energy, Green Products and Waste Treatment.pdf | Dr Mohammad Rehan and Dr. Abdul-Sattar Nizami - Academia.edu](https://0.academia-photos.com/24469417/15302600/28991356/s200_dr_mohammad.rehan.jpg)